Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/1998
03/12/1998DE19636889A1 Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel Antineoplastic acting transferrin and albumin conjugates cytostatic compounds from the group of anthracyclines, alkylating agents, antimetabolites and cisplatin analogues and pharmaceutical compositions containing them
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2266039A1 Alkylated rapamycin derivatives
03/12/1998CA2265526A1 Fatty acid treatment
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264081A1 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998CA2215015A1 Treating prostate hypertrophy and prostate cancer
03/11/1998EP0828005A2 Apoptotic agents for tumor cells of the nervous system
03/11/1998EP0827968A2 Bioactive substance having antitumor activity, producing strain, production ans use thereof
03/11/1998EP0827745A1 Anti-tumour compositions containing taxan derivatives
03/11/1998EP0827546A2 Gene therapy using replication competent targeted adenoviral vectors
03/11/1998EP0827544A2 Multimeric proteins
03/11/1998EP0827412A1 Peptide radiopharmaceutical applications
03/11/1998EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998EP0663902B1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
03/11/1998EP0552188B1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates
03/11/1998CN1175977A Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw* 1601 and uses thereof
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175957A Monoclonal antibodies anti-CD6 and their uses
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/11/1998CN1175573A Vitamin D3 analogs
03/11/1998CN1175572A Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same
03/11/1998CN1175415A Anticancer synergist contg. xanthine methyl derivs. antimelancholic component
03/10/1998US5726318 Process for the preparation of taxane derivatives
03/10/1998US5726304 Porphocyanine and CNC-expanded porphyrins
03/10/1998US5726196 Aromatase-inhibiting composition containing azole derivative
03/10/1998US5726191 Aromatic carboxylic acid esters
03/10/1998US5726184 Tetralin compounds with improved MDR activity
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726167 Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
03/10/1998US5726164 Nanosuspensions for intravenous administration
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5726045 Materials and methods for converting DNA to CO-DNA
03/10/1998US5725895 Method of preparing a food product from cruciferous seeds
03/10/1998US5725855 Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
03/10/1998US5725851 Method and compositions for treating injury
03/06/1998CA2209890A1 Apoptotic agents for tumor cells of the nervous system
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008859A1 Bioconjugates and delivery of bioactive agents
03/05/1998WO1998008856A2 Mirror-symmetrical selection and evolution of nucleic acids
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008849A1 Method for producing epothilones, and intermediate products obtained during the production process
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008829A1 Pharmaceutical compounds
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008546A2 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998WO1998008533A1 Sustained peptide-release formulation
03/05/1998WO1998008518A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998WO1998008513A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998WO1998008506A1 Pharmaceutical compounds
03/05/1998WO1998008505A1 Pharmaceutical compounds
03/05/1998WO1998008503A1 Therapeutic methods and compositions involving isoflavones
03/05/1998WO1998008481A2 PROCESS AND APPARATUS FOR THE PRODUCTION OF Bi-212 AND A USE THEREOF
03/05/1998WO1998008382A1 Nonclassical pyrrolo[2,3-d]pyrimidine antifolates
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1998002452A3 Compounds and methods for modulating cell adhesion
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997047296A3 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
03/05/1998CA2265049A1 Therapeutic methods and compositions involving isoflavones
03/05/1998CA2264297A1 Pharmaceutical compounds
03/05/1998CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263999A1 Integrin antagonists
03/05/1998CA2263998A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263928A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998CA2263907A1 Nonclassical pyrrolo[2,3-d]pyrimidine antifolates
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263817A1 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998CA2263420A1 Pharmaceutical compounds
03/05/1998CA2263175A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998CA2259151A1 Enzyme and dna sequence encoding same
03/04/1998EP0826696A1 Use of bi-and trispecific antibodies for inducing tumor immunity
03/04/1998EP0826695A1 Destruction of contaminating tumor cells in stem cell transplants by use of bispecific antibodies
03/04/1998EP0826683A1 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/04/1998EP0826682A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826680A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
1 ... 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 ... 2211